Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy.
about
Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysisSulphonylurea monotherapy for patients with type 2 diabetes mellitusSulphonylurea monotherapy for patients with type 2 diabetes mellitusInteractions between kidney disease and diabetes: dangerous liaisonsNephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertaintyImprovements in the Management of Diabetic NephropathyEffect of Metformin on Renal Function After Primary Percutaneous Coronary Intervention in Patients Without Diabetes Presenting with ST-elevation Myocardial Infarction: Data from the GIPS-III Trial.Does combined peroxisome proliferator-activated receptors-agonist and pravastatin therapy attenuate the onset of diabetes-induced experimental nephropathy?A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazone.Comparative effectiveness of incident oral antidiabetic drugs on kidney functionThe role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes.Rationale and design of the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE).Comparison of Acarbose and Metformin on Albumin Excretion in Patients With Newly Diagnosed Type 2 Diabetes: A Randomized Controlled TrialChange in albuminuria and eGFR following insulin sensitization therapy versus insulin provision therapy in the BARI 2D study.Renal Protective Effect of DPP-4 Inhibitors in Type 2 Diabetes Mellitus Patients: A Cohort StudyRole of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence.Long-term studies of treatments for type 2 diabetes.Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial.Alprostadil protects type 2 diabetes mellitus patients treated with metformin from contrast-induced nephropathy.Role of the sodium-hydrogen exchanger in mediating the renal effects of drugs commonly used in the treatment of type 2 diabetes.
P2860
Q22241119-ADEC0EB9-F57E-4071-9F6D-BD4603A42A6CQ24186660-DBD2284E-ABC4-4FF3-8618-0944ADA93045Q24197884-A171B9DD-AC1C-4586-8769-DEBB9521807FQ26740630-26D7D254-75F8-4739-A32B-52C89770A83FQ26777994-AFDAB2E8-FDA2-4185-AA09-F3C688FEC2DEQ27024799-FFF75184-4CAE-401A-9CC3-8A916559C21BQ28080717-332CDE3E-99FD-473D-BB56-7D285117C1D9Q31132421-4D384D40-6BA6-4DB5-977C-21E816628DC8Q35183612-B8532F35-9445-4C6E-8DA4-557DDEA25467Q35189862-5F84CDF2-849A-4BCE-8430-30A913887C88Q35835288-E55425A3-7F3D-4E3D-BAC0-5CF3F1E21BB2Q36877514-D0505597-B88C-442F-BF85-1D6A01011A54Q37022623-89B69E7D-13B2-43A2-B312-37AAB301D3EDQ37206677-496069BB-1F46-4B95-9A9B-FD9F00F4A7D6Q37427000-C6648FEA-E73A-43D0-88FA-C91E022FD738Q37581754-62B5586F-79B4-4036-8D93-91A50D469B9CQ38050731-87890F58-D2C2-4059-B25C-055870719F9EQ39018646-E6545C9D-2AA3-4524-A059-D74A2AA012E7Q44424665-63853FD8-6311-4A5B-BECA-E4A55A87A9E2Q47850054-499721AD-A141-4328-BD38-6368B8D8D05DQ48141985-D7968E58-CA7A-4E6C-98E1-F0C0F26F39AD
P2860
Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Renal function in type 2 diabe ...... in, and glyburide monotherapy.
@ast
Renal function in type 2 diabe ...... in, and glyburide monotherapy.
@en
Renal function in type 2 diabe ...... in, and glyburide monotherapy.
@nl
type
label
Renal function in type 2 diabe ...... in, and glyburide monotherapy.
@ast
Renal function in type 2 diabe ...... in, and glyburide monotherapy.
@en
Renal function in type 2 diabe ...... in, and glyburide monotherapy.
@nl
prefLabel
Renal function in type 2 diabe ...... in, and glyburide monotherapy.
@ast
Renal function in type 2 diabe ...... in, and glyburide monotherapy.
@en
Renal function in type 2 diabe ...... in, and glyburide monotherapy.
@nl
P2093
P2860
P50
P356
P1476
Renal function in type 2 diabe ...... in, and glyburide monotherapy.
@en
P2093
ADOPT Study Group
Barbara G Kravitz
Giancarlo Viberti
Gitanjali Paul
R Paul Aftring
Rury R Holman
Steven M Haffner
William H Herman
P2860
P304
P356
10.2215/CJN.09291010
P577
2011-03-31T00:00:00Z